Lupin Limited (Lupin) announced the launch of Bromfenac Ophthalmic Solution, 0.075% after having received an approval from the United States Food and Drug Administration (U.S. FDA). Bromfenac Ophthalmic solution, 0.075% is a generic equivalent of BromSite® Ophthalmic Solution,0.075%, of Sun Pharmaceutical Industries Limited. It is indicated for the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery.